Overview

Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery

Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the use of locally injected tranexamic acid (TXA) under the skin during Mohs micrographic surgery for removal of skin cancers in patients on anticoagulation. TXA may be helpful in reducing bleeding and pain during surgery, and may also lead to fewer post-operative complications following surgery such as graft loss, specifically in patients on blood-thinners.
Phase:
Early Phase 1
Details
Lead Sponsor:
Riley McLean
Treatments:
Epinephrine
Lidocaine
Tranexamic Acid